Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics
- First Online:
- 336 Downloads
Background and Aims
Prior studies have underlined the need for increased screening and awareness of chronic hepatitis B (CHB), especially in certain high-risk populations. However, few studies have examined the patterns of evaluation and management of CHB between primary care physicians (PCP) and specialists according to commonly-used professional guidelines. Our goal was to examine whether necessary laboratory parameters used to determine disease status and eligibility for antiviral therapy were performed by PCPs and specialists.
We conducted a retrospective study of 253 treatment-naïve CHB patients who were evaluated by PCP only (n = 63) or by specialists (n = 190) for CHB at a community multispecialty medical center between March 2007 and June 2009. Criteria for CHB management and treatment eligibility were based on the American Association for the Study of Liver Diseases 2007 guideline and the US Panel 2006 algorithm. Required parameters for optimal evaluation for CHB included hepatitis B e antigen (HBeAg), HBV DNA, and alanine aminotransferase (ALT). Preferred antiviral agents for CHB included pegylated interferon, adefovir, and entecavir.
The majority of patients were Asians (90 %) and male (54 %) with a mean age of 43 ± 11.6 years. Compared to PCPs, specialists were more likely to order laboratory testing for ALT (94 vs. 86 %, P = 0.05), HBeAg (67 vs. 41 %, P < 0.0001) and HBV DNA (83 vs. 52 %, P < 0.0001). The proportion of patients having all three laboratory parameters was significantly higher among those evaluated by specialists compared to PCP (62 vs. 33 %, P < 0.0001). A total of 55 patients were initiated on antiviral treatment (n = 47 by specialists and n = 6 by PCPs). Lamivudine was prescribed more often by PCPs than specialists (33 vs. 2 %, P = 0.05). Preferred agents were used 96 % of the time by specialists compared to 67 % of those treated by PCPs (P = 0.05).
Patients evaluated by specialists for CHB are more likely to undergo more complete laboratory evaluation and, if eligible, are also more likely to be treated with preferred longer-term agents for CHB compared to those evaluated by PCPs only. A collaborative model of care involving both PCP and specialists may further optimize management of patients with CHB.
KeywordsHepatitis B virus Asian American Hepatitis B treatment guidelines Primary care physicians
List of Abbreviations
Hepatitis B virus
Chronic hepatitis B
Hepatitis B e antigen
American Association for the Study of Liver Diseases
- US Panel
United States Panel hepatologists
Primary care physicians
Upper limit of normal
- 3.Centers for Disease Control and Prevention (CDC). Characteristics of persons with chronic hepatitis B–San Francisco, California, 2006. MMWR Morb Mortal Wkly Rep. 2007;446–448.Google Scholar
- 5.Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis—United States, 2007 MMWR Surveill Summ. 2009;1–27.Google Scholar
- 8.Centers for Disease Control and Prevention (CDC). Screening for chronic hepatitis B among Asian/Pacific Islander populations–New York City, 2005. MMWR Morb Mortal Wkly Rep. 2006;505–509.Google Scholar
- 13.Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;1315–1341; quiz 1286.Google Scholar
- 14.Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;661–662.Google Scholar
- 32.Vu LH, Gu Z, Walton J, et al. Hepatitis B knowledge, testing, and vaccination among Chinese and Vietnamese adults in Australia. Asia Pac J Public Health. 2012;24(2):374–384.Google Scholar
- 34.Chang ET, Nguyen BH, So SK. Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area. Calif Asian Pac J Cancer Prev. 2008;9:605–613.Google Scholar
- 36.Taylor VM, Talbot J, Do HH, et al. Hepatitis B knowledge and practices among Cambodian Americans Asian. Pac J Cancer Prev. 2011;12:957–961.Google Scholar